Scientists probe skin cells to unlock scleroderma secrets
NCT ID NCT07256418
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at skin cells called fibroblasts from people with scleroderma and healthy volunteers. Researchers want to find which genes are turned on or off in these cells, especially those linked to aging and inflammation. The goal is to better understand what causes the disease, not to test a new treatment. About 60 adults will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a skin patch ease stomach pain in scleroderma?
- Blood thinner may stop autoimmune disease before it starts
- New antibody drug aims to halt Scleroderma's grip
- Can online therapy help scleroderma patients manage daily life?
- Pandemic stress hits hard for arthritis patients
- New shot aims to tame rare autoimmune disease